Which One Is Better for Treating Constipation, Mosapride or Cisapride?

Cisapride is not recommended for the treatment of constipation due to its potential cardiac and cardiovascular side effects. In fact, this medication has been withdrawn from many markets due to safety concerns. On the other hand, Mosapride is a commonly prescribed prokinetic agent in gastroenterology and is considered suitable for patients suffering from constipation. It works by enhancing motility throughout the digestive tract, particularly in the intestines.

When it comes to targeted treatment for constipation, Prucalopride stands out as a more specialized prokinetic option. This medication is specifically designed to address chronic constipation and offers a more focused therapeutic effect compared to other general prokinetics.

In addition to medication, managing constipation effectively often involves lifestyle modifications such as increased water intake, regular physical activity, and a diet rich in fruits and vegetables. Other treatment options include the use of mild laxatives, osmotic agents, and short-term prokinetic therapy. However, long-term use of stimulant laxatives is generally discouraged due to potential dependency and adverse effects. Therefore, when choosing between Mosapride and Cisapride, healthcare providers typically recommend avoiding Cisapride and opting for Mosapride, which is both safer and more appropriate for treating constipation.